AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Bioworld Financial Watch articles from April 2002

3,200 total articles

Set up an RSS feed
Close Set up an RSS feed that alerts you when new articles from Bioworld Financial Watch are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds
to find out when new articles for Bioworld Financial Watch arrive.

Bioworld Financial Watch archives from April 2002

Would-be competitors eye Amgen's EPO market lock-up.
April 1, 2002... You might not expect onlookers to be especially sanguine about competitors against erythropoietin king Amgen Inc., which continues to reap revenues galore from its blood-boosting blockbuster drug. Last week, though, two companies with EPO...

Money raised by Biotech in 2002 vs. 2001.
April 1, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 - March 28, Jan. 1 - March 29, 2002; $5,019.87M 2001; $2,316M Public/Other (*) 3,346 361 Private Biotechs ...

10 biggest U.S. gainers & losers for the week.
April 1, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Dendrcon 23.31 Cerus Corp. 3.52 Esperion 20.59 Martek Bio 2.27 ViroLogic 17.05 Ncose Technol 2.05...

Biotechnology company deals with other Biotechnology companies: Collaborations, greements, equity participation, Dec. 18, 2001 -- March 25, 2002.
April 1, 2002... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Dec. 18, 2001 -- March 25, 2002 (#) Company (*) Company (*) Type/Product Area (Country, ...

Manufacturing, marketing and distribution agreements between Biotech companies: Dec. 6, 2001 - March 25, 2002.
April 1, 2002... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Dec. 6, 2001 - March 25, 2002 (#) Biotech Co. (*) Biotech Co. (*) Product (Country/ (Country/ Symbol) Symbol) Avid ...

Biotech -- Biotech collaborations modified and terminated agreements, Jan. 1 -- March 25, 2002.
April 1, 2002... Biotech -- Biotech Collaborations Modified And Terminated Agreements, Jan. 1 -- March 25, 2002 (#) I. MODIFIED AGREEMENTS Biotech Co. (*) Biotech Co. (*) Change from original (Country/ (Country/ agreement...

BioWorld stock report for public biotechnology companies.
April 1, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 3/22 3/29 WK YTD 3D Pharma DDDP 6.95 6.83 ...

Alkermes' acquisition of reliant brings 'one-step transformation'.
April 8, 2002... You don't hear the term "overnight sensation" much in biotechnology (in fact, you don't hear it much at all. now that variety show host Ed Sullivan Is gone), but the tag seems just right for Alkermes Inc. -- even if those who know him might...

10 biggest U.S. Gainers & Losers for the week.
April 8, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) GalaGen 116.67 Ccrus Corp. 2.30 Viragen 38.27 Epix Medical 2.05 Synsorb Biotech 36.84 Embrex ...

Money raised by biotech in 2002 vs. 2001.
April 8, 2002... Money Raised by Biotech In 2002 Vs. 2001 Jan. 1 -- April Jan. 1 -- April 4, 2002: 5, 2001: $5,039.58M $2,560M Public/Other (*) 3,350 361...

Public financing of biotechnology: March 2002.
April 8, 2002... I. COMMENCED TRADING IN MARCH INITIAL OFFERINGS There were no initial public offerings conducted in March. Total: $0M Number of IPOs in March: 0 Average value at March IPOs: $OM Number of IPOS in 2002: 1 Total...

Other financings of public Biotechnology Companies: March 2002.
April 8, 2002... Other Financings Of Public Biotechnology Companies: March 2002 TOTAL: $172.15M Company Type of Number Of Amount (Symbol)# Financing Shares, Units Raised ...

Venture Capital and corporate investments in Biotechnology Companies: March 2002.
April 8, 2002... Venture Capital And Corporate Investments In Biotechnology Companies: March 2002 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES Company Location Date Aegera Montreal ...

Money raised by Biotech in 2002: January-March.
April 8, 2002... Money Raised By Biotech In 2002: January-March Type of financing I($M) F($M) M($M) Total($M) Public offerings 75.1 345.8 281.9 702.8 Private blotechs 341.0 241.6 247.3 829.9 Public/other ...

Bioworld stock report for public Biotechnology Companies.
April 8, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 3/29 4/5 WK YTD 3D Pharma DDDP 6.83 6.76 ...

Biotechnology's cancer focus bringing better drugs, no cure.
April 15, 2002... Cancer, Few words strike fear into the heart more than cancer. The disease kills with such proficiency that it is not particularly shocking when someone develops cancer, instead being more significant when cancer is actually defeated....

10 biggest U.S. gainers for the week.
April 15, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (BY Percent) Iata Pharma 86.15 Avant Immumo 36.78 Lynx Thcrapcutica 30.34 Cygnus 25.37 Dyax 19.68 Onyx Pharma 19.32 Rigel ...

10 biggest U.S. losers for the week.
April 15, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Demegen -46.15 Cel-Sci -34.09 Avax Technol -33.33 GalaGen -23.08 Viragen -21.43 Tularik -19.68 Gliatech -19.57 Genz Mol...

Correction.
April 15, 2002... Figures from a financing of a non-biotech company were mistakenly included in the April 8, 2002, Bio World Financial Watch issue. On page 4, the correct figure for the total of March follow-on offerings is $156.9 million. The number of...

Clinical trial update: March 2002.
April 15, 2002... Clinical Trial Update: March 2002 CANCER Company (*) Product Description (Symbol) AltaRex Corp. OvaRex Oregovomab; a fully (Canada; TSE:AXO) foreign monoclonal ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: March 2002.
April 15, 2002... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: March 2002 CANCER Company (*) (Symbol) Product Description Ark EG009 Gene therapy product...

FDA submissions, approvals and other actions: March 2002.
April 15, 2002... FDA Submissions, Approvals And Other Actions: March 2002 CANCER Company (*) (Symbol) Product Description Celgene Corp. Thalomid Thalidomide; (CELG) modulates level of ...

BioWorld stock report for Public Biotechnology Companies.
April 15, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 4/5 4/12 WK YTD 3D Pharma DDDP 6.76 6.41 ...

London stock exchange.
April 15, 2002... LONDON STOCK EXCHANGE Company Symbol 4/5 4/12 % WK % YTD Volume Acambis ACM 323 320 -0.93 -8.70 3454 Antisoma ASM 20.5 20.5 0.00 -42.25 2083 British Biotach BBG ...

Toronto stock exchange.
April 15, 2002... TORONTO STOCK EXCHANGE Company Symbol 4/5 4/12 % WK % YTD Volume Adherex AHX 0.47 0.54 14.89 28.57 563 Angiotech Pharma ANP 72 71.09 -1.26 -20.12 195 Anormed ...

MS data war heats up: Is Avonex stronahold secure?
April 22, 2002... Multiple sclerosis -- as many of those afflicted know all too well -- is characterized in extreme forms by tissue-hardening paralysis, during Its often-painful march through the brains and spinal cords of victims. But the competitive arena for...

10 biggest U.S. gainers & losers for the week.
April 22, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Adolor 54.31 Trimeris 11.05 Avax Technol 45.00 Adolor 5.35 Ccl-Sci 37.93 Vertex Pharma 3.46 British...

Biotech -- Big Pharma Collaborations: New Agreements, Feb. 20 -- April 17, 2002.
April 22, 2002... Biotech -- Big Pharma Collaborations: New Agreements, Feb. 20 -- April 17, 2002 (#) Biotech Co. (*) Pharma Co. (Country; (Country) Symbol) 3M Drug Novartis Pharma AG Delivery ...

Manufacturing, Marketing and Distribution Agreements Between Biotech and Pharmaceutical Companies: Feb. 20 -- April 17, 2002.
April 22, 2002... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Feb. 20 -- April 17, 2002 (#) Biotech Co. (*) (Country; Pharma Co. Symbol) (Country) Product ...

Biotech -- Big Pharma Collaborations: Modified and Terminated Agreements, Feb. 20 -- April 17, 2002.
April 22, 2002... Biotech -- Big Pharma Collaborations: Modified And Terminated Agreements, Feb. 20 -- April 17, 2002 (#) I. MODIFIED AGREEMENTS Biotech Co. (*) Pharma Co. (Country: Symbol) (Country) Applied Eli Lilly and...

BioWorld Stock Report for Public Biotechnology Companies.
April 22, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 4/5 4/12 WK YTD 3D Pharma DDDP 6.41 6.81 ...

London Stock Exchange.
April 22, 2002... LONDON STOCK EXCHANGE Company Symbol 4/5 4/12 %WK %YTD Volume Acambis ACM 320 313 -2.19 -10.70 2869 Antisoma ASM 20.5 20.5 0.00 42.25 523 British Biotech BBG...

Toronto Stock Exchange.
April 22, 2002... TORONTO STOCK EXCHANGE Company Symbol 4/5 4/12 %WK %YTD Volume Adherex AHX 0.54 0.52 -3.70 23.81 166 Angiotech Pharma ANP 71.09 73.75 3.74 -17.13 113 Anormed ...

Money Raised by Biotech in 2002 Vs. 2001.
April 22, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 -- April 18, Jan. 1 -- April 19, 2002: $5,485.22M 2001: $2,766M Public/Other (*) 3,538 421 Private Biotechs ...

ESO accounting changes could hurt biotech hiring, bottom lines.
April 29, 2002... As if implications of the Enron Corp. situation hadn't already messed things up enough for biotechnology (and Just about every other sector that uses balance sheets and ledgers), another spawn of the scandal has reared its head for industry...

10 biggest U.S. gainers for the Week.
April 29, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Select Therapeu 78.57 Immucor 2.50 Interleukin 42.00 Tripos 2.34 Immune Rcsp 36.96 Cholestech 1.60...

Money raised by biotech in 2002 vs. 2001.
April 29, 2002... Money Raised By Biotech in 2002 vs. 2001 Millions Jan. 1 - April 25, Jan. 1 - April 26, 2000: $6,343.24M 2000: $2,884M Public/Other (*) 4,242 ...

Correction.
April 29, 2002... The stock charts on pages 14 and 15 in the April 22, 2002, issue of BioWorld Financial Watch had the wrong headers. They should have said 4/12 and 4/19 instead of 4/5 and 4/12. The stock closing prices were correct. Editor's note: The...

Biotech Mergers and Acquisitions: Feb. 28 - April 25, 2002.
April 29, 2002... Biotech Mergers and Acquisitions: Feb. 28 - April 25, 2002 (#) I. COMPLETED MERGERS AND ACQUISITIONS Acquired By Or Merged Date Company Acquired (*) With (*) Announced...

BioWorld stock report for public biotechnology companies.
April 29, 2002... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close 4/19 4/26 WK YTD ...

London stock exchange.
April 29, 2002... LONDON STOCK EXCHANGE Company Symbol 4/19 4/26 %WK %YTD Volume Acambis ACM 313 295 -5.75 -15,83 3562 Antiaoma ASM 20.5 22 7.32 -38.03 5429 British Biotech BBG...

Toronto stock exchange.
April 29, 2002... TORONTO STOCK EXCHANGE Company Symbol 4/19 4/26 %WK %YTD Volume Adherex AHX 0.52 0.56 7.69 33.33 514 Angiotech Pharma ANP 73.75 62.1 -15.80 -30.22 366 Anormed ...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA